| Literature DB >> 33330585 |
Julia Spielmann1, Wiebke Naujoks1, Matthias Emde1, Martin Allweyer1, Heike Kielstein1, Dagmar Quandt1,2, Ina Bähr1.
Abstract
Overweight and obesity are major public health challenges worldwide. Obesity is associated with a higher risk for the development of several cancer types, but specific mechanisms underlying the link of obesity and cancer are still unclear. Natural killer (NK) cells are circulating lymphoid cells promoting the elimination of virus-infected and tumor cells. Previous investigations demonstrated conflicting results concerning the influence of obesity on functional NK cell parameters in small animal models. The aim of the present study was to clarify potential obesity-associated alterations of murine NK cells in vivo, implementing different feeding regimes. Therefore, C57BL/6 mice were fed a normal-fat diet (NFD) or high-fat diet (HFD) under restrictive and ad libitum feeding regimes. Results showed diet and feeding-regime dependent differences in body weight, visceral fat mass and plasma cytokine concentrations. Flow cytometry analyses demonstrated significant changes in total cell counts as well as frequencies of immune cell populations in peripheral blood comparing mice fed NFD or HFD in an ad libitum or restrictive manner. Mice fed the HFD showed significantly decreased frequencies of total NK cells and the mature CD11b+CD27+ NK cell subset compared to mice fed the NFD. Feeding HFD resulted in significant changes in the expression of the maturation markers KLRG1 and CD127 in NK cells. Furthermore, real-time PCR analyses of NK-cell related functional parameters in adipose tissue revealed significant diet and feeding-regime dependent differences. Most notable, real-time cytotoxicity assays demonstrated an impaired cytolytic activity of splenic NK cells toward murine colon cancer cells in HFD-fed mice compared to NFD-fed mice. In conclusion, our data demonstrate that feeding a high-fat diet influences the frequency, phenotype and function of NK cells in C57BL/6 mice. Interestingly, restricted feeding of HFD compared to ad libitum feeding resulted in a partial prevention of the obesity-associated alterations on immune cells and especially on NK cells, nicely fitting with the current concept of an advantage for interval fasting for improved health.Entities:
Keywords: NK cell receptors; NK cell subsets; NK cells; cancer; cytotoxicity; mice; obesity; overweight
Year: 2020 PMID: 33330585 PMCID: PMC7728990 DOI: 10.3389/fnut.2020.585693
Source DB: PubMed Journal: Front Nutr ISSN: 2296-861X
Figure 1Effects of high-fat diet (HFD) and normal-fat diet (NFD) under ad libitum (ad lib.) and restrictive (restr.) feeding regimes on male C57BL/6 mice. Body weight gain (A), terminal body weight (B) and visceral fat mass (C) after 17 weeks of feeding the diets. Representative pictures for visual differences in body weight of C57BL/6 mice fed NFD ad libitum and HFD ad libitum (D) and visceral fat mass of C57BL/6 mice fed NFD ad libitum or restrictive and HFD ad libitum or restrictive (E) after 17 weeks of feeding the diets. *P < 0.05, HFD ad libitum compared to NFD ad libitum group. #P < 0.05, HFD restrictive compared to NFD restrictive group. Means with different letters are significantly different according to post-hoc Tukey's multiple comparison test results (P ≤ 0.05). ***P ≤ 0.001, two-way ANOVA, NFD-fed groups compared to HFD-fed groups. Data are presented as mean ± SEM.
Figure 2Multiplex analyses of plasma cytokine concentrations of interleukin (IL)-2 (A), IL-6 (B), interferon (IFN)-γ (C) and tumor necrosis factor (TNF)-α (D) in C57BL/6 mice fed a high-fat diet (HFD) and normal-fat diet (NFD) under ad libitum (ad lib.) and restrictive (restr.) feeding regimes. Means with different letters are significantly different according to post-hoc Tukey's multiple comparison test results (P ≤ 0.05). *P ≤ 0.05, two-way ANOVA, NFD-fed groups compared to HFD-fed groups. Data are presented as mean ± SEM.
Figure 3Flow cytometric analyses of immune cell subsets in blood. Absolute cell counts (A) and frequencies (B) of immune cell populations in whole blood samples of C57BL/6 mice fed either a high-fat diet (HFD) or normal-fat diet (NFD) under ad libitum (ad lib.) and restrictive (restr.) feeding regimes. Means with different letters are significantly different according to post-hoc Tukey's multiple comparison test results (P ≤ 0.05). *P ≤ 0.05 and exact P-values within 0.05 ≤ P ≤ 0.1, two-way ANOVA, NFD-fed groups compared to HFD-fed groups. Data are presented as mean ± SEM. **P ≤ 0.01; ***P ≤ 0.001.
Figure 4Flow cytometric analyses of NK cells and NK cell subsets in whole blood samples of C57BL/6 mice fed either a high-fat diet (HFD) or normal-fat diet (NFD) under ad libitum (ad lib.) and restrictive (restr.) feeding regimes. Concentration of total NK cells (A), expressed as absolute cell number per μl, and percentages of total NK cells (B). Percentages of NK cell subsets with different surface expression profiles of CD11b and CD27 (C–F). *P ≤ 0.05; ***P ≤ 0.001 and exact P-values within 0.05 ≤ P ≤ 0.1, two-way ANOVA, NFD-fed groups compared to HFD-fed groups. Means with different letters are significantly different according to post-hoc Tukey's multiple comparison test results (P ≤ 0.05). Data are presented as mean ± SEM.
Figure 5(A–C) Flow cytometric analyses of frequencies or median fluorescent intensities (MFIs) of total NK cells of C57BL/6 mice expressing the activation-associated receptor CD69 (A) or the co-activating receptors 2B4 (B) and CD122 (C). (D–L) Frequencies or MFIs of total NK cells, CD11b+CD27+NK cells and CD11b+CD27− NK cells of C57BL/6 mice expressing the activating receptor NKG2D (D–F), the activating receptor CD161 (G–I) or the inhibitory and activating receptors Ly49C/F/I/H (J–L). Mice were fed either a high-fat diet (HFD) or normal-fat diet (NFD) under ad libitum (ad lib.) or restrictive (restr.) feeding regimes. Data are presented as mean ± SEM.
Figure 6(A,B) Flow cytometric analyses of frequencies of total NK cells of C57BL/6 mice expressing the adhesion molecule CD62L (A) and the maturation marker killer cell lectin-like receptor G1 (KLRG1, B). (C–E) Frequencies of total NK cells, CD11b+CD27+NK cells and CD11b+CD27− NK cells of C57BL/6 mice expressing the maturation marker CD127. (B–D) Mice were fed either a high-fat diet (HFD) or normal-fat diet (NFD) under ad libitum (ad lib.) or restrictive (restr.) feeding regimes. Means with different letters are significantly different according to post-hoc Tukey's multiple comparison test results (P ≤ 0.05). *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, two-way ANOVA, NFD fed groups compared to HFD fed groups. Data are presented as mean ± SEM.
Figure 7Cytolytic activity of primary splenic NK cells of C57BL/6 mice against the colon cancer target cell line CT26.WT at 15 min, 45 min, and 12 h after NK cell addition determined by the real-time xCELLigence system. Mice were fed a normal-fat diet (NFD) or a high-fat diet (HFD) with both ad libitum (ad lib.) and restrictive (restr.) feeding regimes. *P ≤ 0.05 and **P ≤ 0.01 indicate results of two-way ANOVA for the main factor diet. Data are presented as mean ± SEM.; n = 2–4 (per group).
Real-time polymerase chain reaction (PCR) analyses of effects of high-fat diet (HFD) and normal-fat diet (NFD) on relative mRNA expression of NK cells, activating and inhibitory NK cell receptors, NK cell-related transcription factors, NKG2D-receptor ligands and cytokines in visceral adipose tissue under ad libitum and restrictive feeding regimes in C57BL/6 mice.
| Activating NK cell receptors | Fcgr3 (CD16) | 1 ± 0.222b | 0.626 ± 0.097b | 5.049 ± 0.801a | 1.704 ± 0.263b | <0.0001 | 0.0015 | 0.0089 |
| Klra4 (Ly49d) | 1 ± 0.134 | 0.993 ± 0.189 | 1.079 ± 0.201 | 0.873 ± 0.110 | 0.9061 | 0.5312 | 0.5595 | |
| Klra8 (Ly49h) | 1 ± 0.134 | 0.731 ± 0.069 | 0.820 ± 0.124 | 0.770 ± 0.062 | 0.1864 | 0.7611 | 0.9552 | |
| Klra22 (Ly49s2) | 1 ± 0.137 | 0.693 ± 0.063 | 1.136 ± 0.182 | 0.754 ± 0.063 | 0.4760 | 0.0172 | 0.7837 | |
| Klrb1c (NK1.1, CD161) | 1 ± 0.132b | 1.297 ± 0.185ab | 2.007 ± 0.270a | 1.204 ± 0.140b | 0.0383 | 0.2388 | 0.0140 | |
| Klrk1 (NKG2D) | 1 ± 0.138 | 0.785 ± 0.113 | 1.161 ± 0.172 | 0.772 ± 0.097 | 0.5886 | 0.0340 | 0.5274 | |
| NCR1 (NKp46, CD335) | 1 ± 0.134 | 0.976 ± 0.135 | 1.162 ± 0.152 | 0.897 ± 0.100 | 0.7590 | 0.2899 | 0.3777 | |
| Activation-associated NK cell receptor | CD69 | 1 ± 0.248 | 0.637 ± 0.029 | 0.867 ± 0.126 | 0.578 ± 0.062 | 0.4756 | 0.0207 | 0.7826 |
| Co-activating NK cell receptor | CD244 (2B4) | 1 ± 0.238ab | 0.780 ± 0.079b | 1.758 ± 0.353a | 1.179 ± 0.139ab | 0.0264 | 0.1176 | 0.4760 |
| Inhibitory NK cell receptors | Klra1 (Ly49a) | 1 ± 0.132 | 0.865 ± 0.116 | 0.803 ± 0.102 | 0.627 ± 0.051 | 0.0371 | 0.1297 | 0.8365 |
| Klra2 (Ly49b) | 1 ± 0.118ab | 0.825 ± 0.088b | 1.569 ± 0.173a | 1.407 ± 0.197ab | 0.0024 | 0.341 | 0.9726 | |
| Klra3 (Ly49c) | 1 ± 0.170 | 0.828 ± 0.145 | 1.154 ± 0.213 | 0.747 ± 0.053 | 0.8226 | 0.4715 | ||
| Klra5 (Ly49e) | 1 ± 0.115 | 0.719 ± 0.075 | 1.049 ± 0.196 | 0.702 ± 0.052 | 0.9052 | 0.0269 | 0.8101 | |
| Klra6 (Ly49f) | 1 ± 0.164 | 0.688 ± 0.087 | 0.877 ± 0.178 | 0.537 ± 0.058 | 0.3253 | 0.0235 | 0.9199 | |
| Klra7 (Ly49g) | 1 ± 0.111 | 0.792 ± 0.146 | 0.898 ± 0.102 | 0.661 ± 0.064 | 0.2777 | 0.0430 | 0.8886 | |
| Klra9 (Ly49i) | 1 ± 0.159 | 0.761 ± 0.098 | 1.014 ± 0.172 | 0.734 ± 0.065 | 0.9788 | 0.8957 | ||
| Klra10 (Ly49j) | 1 ± 0.125ab | 0.743 ± 0.091ab | 1.195 ± 0.183a | 0.710 ± 0.059b | 0.5466 | 0.0088 | 0.3947 | |
| Klrc1 (NKG2A) | 1 ± 0.206 | 0.608 ± 0.058 | 1.107 ± 0.167 | 0.802 ± 0.113 | 0.3261 | 0.0274 | 0.7750 | |
| Klrd1 (CD94) | 1 ± 0.150ab | 0.841 ± 0.090b | 1.542 ± 0.218a | 1.026 ± 0.084ab | 0.0288 | 0.0413 | 0.2684 | |
| Co-inhibitory NK cell receptor | PDCD1 (PD-1, CD279) | 1 ± 0.062ab | 0.836 ± 0.130b | 1.537 ± 0.232a | 0.990 ± 0.061ab | 0.0456 | 0.2681 | |
| Transcription factors | Eomes | 1 ± 0.284ab | 0.629 ± 0.040b | 1.268 ± 0.169a | 0.704 ± 0.057b | 0.2930 | 0.0065 | 0.5507 |
| Tbx21 (T-bet) | 1 ± 0.097ab | 0.848 ± 0.059b | 1.853 ± 0.35a | 0.873 ± 0.106b | 0.0220 | |||
| NKG2D receptor ligands | Ulbp1 (MULT-1) | 1 ± 0.117b | 0.739 ± 0.051b | 5.292 ± 0.67a | 2.380 ± 0.255b | <0.0001 | 0.0013 | 0.006 |
| Rae1 (RAE-1) | 1 ± 0.098 | 0.817 ± 0.114 | 0.775 ± 0.081 | 0.795 ± 0.081 | 0.2302 | 0.4275 | 0.3225 | |
| Cytokines | TNF-α | 1 ± 0.205b | 0.568 ± 0.067b | 3.821 ± 0.652a | 2.232 ± 0.475ab | 0.0002 | 0.2757 | |
| TNFsf10 (TRAIL) | 1 ± 0.177 | 0.770 ± 0.126 | 0.662 ± 0.057 | 0.642 ± 0.087 | 0.0406 | 0.2610 | 0.3440 | |
CD, cluster of differentiation; Eomes, eomesodermin; Fcgr-3, Fc gamma receptor-3; HFD, high-fat diet; Klr, killer cell lectin-like receptor; MULT-1, mouse UL16-binding protein-like transcript 1; NCR, natural cytotoxicity receptor; NFD, normal-fat diet; NKG, natural killer group; PCR, polymerase chain reaction; PD-1, programmed cell death receptor-1; Ppia, peptidylprolyl isomerase A; Rae-1, retinoic acid early inducible-1 gene; SEM, standard error of the mean; T-bet, T-cell associated transcription factor; Tbx21, T-box transcription factor 21; TNF, tumor necrosis factor; TRAIL, tumor necrosis factor related apoptosis inducing ligand; Ulbp-1, UL16-binding protein−1. Different superscript letters (a, b) indicate significant differences between individual experimental groups analyzed by Tukey's multiple comparison test (P ≤ 0.05). For two-way ANOVA analyses, P-values are shown for the main factors diet, feeding regime and the interaction of both main factors. Significant differences are printed in bold type. Italic P-values indicate a tendency to significance (0.5 ≤ P ≤ 0.1).